You are here

Governments may onshore part of biopharma supply chain, but it won't be easy: Panel


THE Covid-19 pandemic has exposed vulnerabilities in the global biopharmaceutical supply chain, raised renewed concerns over the offshoring of facilities to Asia and highlighted the heavy reliance on large producer markets - such as China and India - for critical medical...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to